IanD
Well-Known Member
- Messages
- 2,429
- Location
- Peterchurch, Hereford
- Type of diabetes
- Type 2
- Treatment type
- Tablets (oral)
- Dislikes
- Carbohydrates
IanD said:cocacola said:Can someone please explain this report in plain English?They have found that using high medication to achieve HBA below 7.5 may be counter-productive because of the adverse effects of the medication. At higher HBAs, the adverse effect of diabetes becomes more significant.But it also showed there was a U-shaped association between increased all-cause mortality above and below an HbA1c of 7.5%. Changes above or below an HbA1c of 7.5% was associated with a greater risk, regardless of whether treatment was intensified with oral hypoglycaemic agents or insulin injections.
I understood that "intensified treatment" implied high medication. If HBAs below 7.5 increase the risk, then non-diabetics & diet/exercise controlled diabetics are also at increased risk.
There is a line of thought that diabetes (particularly T1, with DAFNE) can be controlled by medication, while eating normally. That is where Hana & I & others take issue. A reduced carb diet will not have such adverse effects. Hana's husband has been T1 for many years.
Dose Adjustment For NORMAL Eating. I am not challenging the experts but commenting on the cited study. High BG is bad, & intensified drug treatment to achieve BG<7.5 is also bad. Did the study consider reduced carb, so that BG could be reduced below 7.5 with less intense oral hypoglycaemic agents or insulin injections?
jopar said:T2 will always be difficult as in the main it hits later in life, when many life style choose have become ingrained, bad eating habbits are harder to break, it's more diffiuclut to maintain motivation or physically difficult to maintain a good level of exercise there are many factors involved in their outcomes...
An NHS prescribing advisory body has called for a change in diabetes guidance to include a minimum HbA1c target level, reflecting the weight of trial data suggesting lowering blood sugar below a certain level may harm patients.
The National Prescribing Centre suggests the change may have to be considered in light of mounting evidence that driving levels down to below the 7.5% recommended in the QOF increases the risk of cardiovascular events.
If "normal eating" as in DAFNE requires correcting by insulin for the carbs eaten, then that may be contributing to the problem reported in the article.
Whether our data and findings from
the ACCORD study apply to patients with type 1 diabetes
is unclear and needs to be investigated. These data imply
for oral combination therapy that a wide HbA1c range is
safe with respect to all-cause mortality and large-vessel
events, but for insulin-based therapy, a more narrow
range might be desirable.This implication does not
mean that there is unquestionable value in achievement
of present glycaemic targets for reduction of microvascular
disease.
From 31 May 2011, HbA1c will be given in millimoles per mol (mmol/mol) instead of as a percentage (%).
To help make this transition as easy as possible, all HbA1c results in the UK will be given in both percentage and mmol/mol from 1 June 2009 until 31 May 2011.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?